Full-Time

Manufacturing Process Engineer

Posted on 9/9/2026

Cellanome

Cellanome

51-200 employees

Automated platform for live single-cell assays

Compensation Overview

$160k - $210k/yr

+ Equity

Foster City, CA, USA

In Person

Bachelor's, Master's

Category
Manufacturing & Process Engineering (1)
Required Skills
Minitab
ERP
Supply Chain Management
Six Sigma
GMP
Data Analysis

Get referred to Cellanome

See people who can refer or advise you

Requirements
  • Bachelor's degree in Mechanical, Chemical, Biochemical, Materials Science, or related Engineering discipline.
  • Typically requires 12 years of progressive experience in manufacturing/process engineering, spanning new product introduction, continuous improvement, and sustaining engineering within a consumables, medical device, or life sciences manufacturing environment.
  • Demonstrated experience leading new product introductions from development through full-scale production launch.
  • Strong hands-on experience in cleanroom and/or ISO/cGMP manufacturing environments.
  • Proficient in process validation methodologies including IQ/OQ/PQ, Failure Mode and Effects Analysis, root cause analysis, and Corrective and Preventive Action processes.
  • Working knowledge of statistical tools including Statistical Process Control, Design of Experiments, Minitab, JMP, or similar tools for process characterization and improvement.
  • Proficient in utilizing artificial intelligence tools to conduct experimental design and data analysis and to build manufacturing KPI, Statistical Process Control charting, and monitoring systems.
  • Excellent cross-functional communication and project management skills, with the ability to represent Operations on cross-functional teams and influence technical and business decisions.
  • Ability to author, review, and maintain technical documentation including standard operating procedures, protocols, work instructions, and batch records.
  • Ability to perform the essential duties of the position with or without reasonable accommodations.
  • Ability to lift up to 30 pounds occasionally and comply with personal protective equipment requirements.
  • Ability to work hands-on in a manufacturing cleanroom environment as needed to support troubleshooting, validation, and process development activities.
  • Ability to grasp with both hands, pinch with thumb and forefinger, turn with hand or arm, and reach above shoulder height.
Responsibilities
  • Lead new process transfer and qualification of new consumable manufacturing processes, transitioning products from research and development and pilot scale into full-scale production.
  • Represent Consumable Life Cycle Management on cross-functional teams throughout the product development lifecycle, providing manufacturability, process, and operational input into design and business decisions.
  • Own sustaining engineering support for released consumable products, including troubleshooting, root cause analysis using 5-Why, fishbone, and 8D methods, and implementation of Corrective and Preventive Actions.
  • Investigate and resolve non-conformances and deviations.
  • Identify, prioritize, and lead continuous improvement projects to improve yield, cycle time, capacity, and cost of goods across consumable manufacturing lines.
  • Partner with the Product Development Team to develop tech transfer deliverables, including product bills of materials, manufacturing process design, process Failure Mode and Effects Analysis, control plans, equipment sourcing and onboarding, and process work instructions.
  • Partner with the broader Operations Team to complete operational readiness for new consumable products, including batch records, space control, labeling and packaging, supply chain readiness, manufacturing capacity and capability, and staff training.
  • Develop and optimize process performance monitoring systems and apply Lean Manufacturing, Six Sigma, Statistical Process Control, and Design of Experiments methodologies to optimize processes and reduce variation.
Desired Qualifications
  • Advanced degree.
  • Experience with flow cells, microfluidics, reagents, or other single-cell/genomics consumable manufacturing.
  • Lean/Six Sigma Green Belt or Black Belt certification.
  • Project Management Professional certification.
  • Experience with manufacturing automation implementation and scale-up.
  • Experience with manufacturing enterprise resource planning, manufacturing execution systems, product lifecycle management, and web-based batch record systems.
  • Prior experience in a fast-paced start-up environment and comfort working across multiple functions.

Cellanome provides an automated platform for live-cell phenotypic and functional assays that analyze single cells at scale. It runs high-throughput experiments that integrate with existing lab workflows, collecting multi-parameter data and allowing iterative testing under different conditions. The system emphasizes single-cell granularity, scalable data collection, and easy assay customization without major process changes. Its goal is to help life sciences, medical research, pharmaceutical, and biotech teams gain deeper cellular insights to accelerate discovery through a platform-as-a-service model.

Company Size

51-200

Company Stage

Series C

Total Funding

$276.9M

Headquarters

Foster City, California

Founded

2020

Get referred to Cellanome

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Cellanome updated its website August 2026, showing active product and content momentum.
  • AGBT March 2026 coverage and April 2026 posters show expanding scientific validation.
  • Psomagen added R3200 on March 26, 2026, expanding external distribution and credibility.

What critics are saying

  • The June 22, 2026 $75.9 million Form D signals continued capital dependence.
  • Psomagen's March 26, 2026 launch validates Cellanome while commoditizing its core workflow.
  • Any R3200 commercialization stumble kills a hardware-plus-consumables model before recurring revenue matures.

What makes Cellanome unique

  • R3200 pairs live-cell imaging with single-cell transcriptomics from the same cells.
  • CellCage technology keeps cells viable, trackable, and measurable over time.
  • Omead Ostadan’s December 2025 debut signaled a platform-first strategy across multi-omics biology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Stock Options

401(k) Retirement Plan

Flexible Work Hours

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

57%

2 year growth

0%
U.S. Securities and Exchange Commission
Jul 17th, 2026
EDGAR Filing Documents for 0000905148-26-003005

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231Type: D | Act: 33 | File No.: 021-588010 | Film No.: 261104659

Intelligence360 News
Jul 17th, 2026
Cellanome files to raise $75.9M for live-cell imaging and single-cell transcriptomics platform

Cellanome has filed a notice with the US Securities and Exchange Commission to raise up to $75.9 million in new funding. The filing was made under Regulation D of the Securities Act of 1933, which allows companies to sell securities without full registration. The company develops technologies that combine longitudinal live-cell imaging with single-cell transcriptomics from the same cells. This approach enables scientists to capture cellular dynamics over time and connect cellular behaviour with molecular state. Researchers can access Cellanome's technology by implementing its R3200 platform in their laboratories, using its assay services, or collaborating with the company's scientists on new applications.

The Business Journals
Jan 30th, 2024
Peninsula startup with Illumina roots lands $150 million to peer deeper into cells

A Peninsula startup launched by top former Illumina execs raises $150 million to help researchers see what happens when cells dance with each other.

The Business Journals
Dec 8th, 2021
Former Illumina execs, Grail co-founder raise $21M for biotech startup

Biotech A-listers have come together to launch a new venture. What's it targeting? They're not saying.